Controlled Medication Security and Medication Administration Errors
Summary
Pharmaceutical services were not provided in accordance with accepted professional standards and facility policies when controlled medications were not securely maintained and were not effectively destroyed. During observations of the DON’s office, the controlled medication destruction bin was left unsecured and accessible while the DON was not present. The bin contained multiple medications mixed with only a minimal amount of chemical solution, and several whole, undissolved tablets were visible on top of the contents. One observation identified five intact white oblong pills with imprint code IP 109 that were still retrievable from the bin. The DON stated controlled medications were typically destroyed in the presence of the pharmacist and that medications should be secured under double lock to prevent access. The pharmacist stated the chemical solution was intended to dissolve the controlled medications and that the bin should be kept locked to ensure security. Resident 46, who had diagnoses including CVA and hyperlipidemia and was cognitively intact for daily decision making, had an order for lisinopril 5 mg daily for hypertension. On review of the MAR, the dose was due at 9:00 a.m., but the medication had not been delivered to the facility after the order was placed four days earlier. The LVN stated the medication was not available in the facility’s emergency supply kit and confirmed it was important to have the medication readily available for timely administration. The LVN stated this placed the resident at risk for uncontrolled blood pressure. The MAR for Resident 46 also showed lisinopril documented as administered on two occasions when the medication was not actually given because it was not available. Two LVNs stated they documented the medication in error and confirmed the resident did not receive the ordered dose on those dates. Resident 16, who had diagnoses including gastrointestinal hemorrhage, g-tube status, and GERD and was severely cognitively impaired and entirely dependent on staff for ADLs, was observed receiving famotidine 20 mg via g-tube at 7:59 a.m. The MAR showed the medication was ordered for 11:00 a.m. The LVN admitted the dose was given early and stated the resident was at risk for gastrointestinal issues since the feeding was scheduled to stop shortly.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.